91 related articles for article (PubMed ID: 6742031)
21. The effects of intrauterine contraceptive devices on the ultrastructure of the endometrium in relation to bleeding complications.
Sheppard BL; Bonnar J
Am J Obstet Gynecol; 1983 Aug; 146(7):829-39. PubMed ID: 6869454
[TBL] [Abstract][Full Text] [Related]
22. Levonorgestrel-releasing intrauterine device-wearing women express contraceptive glycodelin A in endometrium during midcycle: another contraceptive mechanism?
Mandelin E; Koistinen H; Koistinen R; Affandi B; Seppälä M
Hum Reprod; 1997 Dec; 12(12):2671-5. PubMed ID: 9455833
[TBL] [Abstract][Full Text] [Related]
23. A comparative study of the effects of an estradiol-releasing vaginal ring combined with an oral gestagen versus transdermal estrogen combined with a levonorgestrel-releasing IUD: clinical findings and endometrial response.
Kalogirou D; Antoniou G; Karakitsos P; Kalogirou O; Antoniou D; Giannikos L
Int J Fertil Menopausal Stud; 1996; 41(6):522-7. PubMed ID: 9010746
[TBL] [Abstract][Full Text] [Related]
24. Morphological and functional features of endometrial decidualization following long-term intrauterine levonorgestrel delivery.
Critchley HO; Wang H; Jones RL; Kelly RW; Drudy TA; Gebbie AE; Buckley CH; McNeilly AS; Glasier AF
Hum Reprod; 1998 May; 13(5):1218-24. PubMed ID: 9647550
[TBL] [Abstract][Full Text] [Related]
25. Benefit-risk assessment of the levonorgestrel intrauterine system in contraception.
Backman T
Drug Saf; 2004; 27(15):1185-204. PubMed ID: 15588115
[TBL] [Abstract][Full Text] [Related]
26. [The effect of intrauterine contraceptive devices on the endometrium].
Sheppard BL; Bonnar J
Contracept Fertil Sex (Paris); 1987 Nov; 15(11):1015-24. PubMed ID: 12341565
[TBL] [Abstract][Full Text] [Related]
27. Lactation pattern in Egyptian women using the Progestasert system.
Badraoui MH; Askalani H; Mahrous I; Serour G; Hefnawi F
Contracept Deliv Syst; 1982 Jan; 3(1):53-60. PubMed ID: 12264128
[TBL] [Abstract][Full Text] [Related]
28. Hormonal profile in IUD users.
Souka AR; Rahman H; Osman M; Mohei Y; Rizk M
Contracept Deliv Syst; 1981 Oct; 2(4):303-10. PubMed ID: 12336991
[TBL] [Abstract][Full Text] [Related]
29. Reduced menstrual blood loss by release of an antifibrinolytic agent from intrauterine contraceptive devices.
Tauber PF; Kloppel A; Goodpasture JC; Burns J; Ludwig H; Zaneveld LJ
Am J Obstet Gynecol; 1981 Jun; 140(3):322-8. PubMed ID: 7246636
[TBL] [Abstract][Full Text] [Related]
30. Effects of levonorgestrel-releasing intrauterine system and T380A intrauterine copper device on dysmenorrhea and days of bleeding in women with and without adenomyosis.
Kelekci S; Kelekci KH; Yilmaz B
Contraception; 2012 Nov; 86(5):458-63. PubMed ID: 22832203
[TBL] [Abstract][Full Text] [Related]
31. Biodegradable polylactate as a steroid-releasing polymer: intrauterine administration of d-norgestrel.
Nilsson CG; Johansson ED; Jackanicz TM; Luukkainen T
Am J Obstet Gynecol; 1975 May; 122(1):90-5. PubMed ID: 1130448
[TBL] [Abstract][Full Text] [Related]
32. Complications associated with the unsuspected presence of intrauterine contraceptive devices.
Porges RF
Am J Obstet Gynecol; 1973 Jun; 116(4):579-80. PubMed ID: 4709493
[TBL] [Abstract][Full Text] [Related]
33. D-norgestrel slow-releasing T device as an intrauterine contraceptive.
El-Mahgoub
Am J Obstet Gynecol; 1975 Sep; 123(2):133-8. PubMed ID: 1163576
[TBL] [Abstract][Full Text] [Related]
34. Efficacy, acceptability and side effects of the levonorgestrel intrauterine system for menorrhagia.
Kriplani A; Singh BM; Lal S; Agarwal N
Int J Gynaecol Obstet; 2007 Jun; 97(3):190-4. PubMed ID: 17382331
[TBL] [Abstract][Full Text] [Related]
35. Immediate postplacental insertion of GYNE-T 380 and GYNE-T 380 postpartum intrauterine contraceptive devices: randomized study.
Tatum HJ; Beltran RS; Ramos R; Van Kets H; Sivin I; Schmidt FH
Am J Obstet Gynecol; 1996 Nov; 175(5):1231-5. PubMed ID: 8942493
[TBL] [Abstract][Full Text] [Related]
36. Clinical study of a progesterone-releasing intrauterine contraceptive device.
Brenner PF; Cooper DL; Mishell DR
Am J Obstet Gynecol; 1975 Mar; 121(5):704-6. PubMed ID: 1115173
[TBL] [Abstract][Full Text] [Related]
37. Menstrual characteristics and ultrasonographic uterine cavity measurements predict bleeding and pain in nulligravid women using intrauterine contraception.
Kaislasuo J; Heikinheimo O; Lähteenmäki P; Suhonen S
Hum Reprod; 2015 Jul; 30(7):1580-8. PubMed ID: 25990577
[TBL] [Abstract][Full Text] [Related]
38. No increase of the fibrinolytic activity of the human endometrium by progesterone-releasing IUD (ProgestasertR).
Liedholm P; Sjöberg NO; Srivastava K; Astedt B
Contraception; 1978 Jun; 17(6):531-6. PubMed ID: 720058
[TBL] [Abstract][Full Text] [Related]
39. Serum cortisol level in lactating women using Progestasert system.
Askalani H; Badraoui MH; Mahrous T; Osman MI; Bayad MA; Ibrahim II; Abdalla MI
Popul Sci; 1981; (2):109-14. PubMed ID: 12339476
[TBL] [Abstract][Full Text] [Related]
40. Intrauterine devices containing progesterone.
Murad F
Drug Ther (NY); 1977 May; 7(5):119-21. PubMed ID: 12277687
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
